Skip to main content

Gastric Cancer Among Asian Americans

  • Chapter
  • First Online:
Cancer Epidemiology Among Asian Americans

Abstract

Gastric cancer is the third leading cause of cancer mortality worldwide. It remains the eighth most commonly diagnosed cancer among Asian American men and women in the United States (USA) with considerable heterogeneity in incidence rates across Asian American subgroups, highest in Korean American men. Because of the lack of routine screening for gastric cancer in the USA, patients are usually diagnosed at a late stage because of symptoms. While infection with Helicobacter pylori is the primary risk factor for gastric cancer, only a small proportion of those infected go on to develop gastric cancer, which means that better understanding of the interactions between H. pylori infection and other lifestyle factors (e.g., cigarette smoking, dietary factors) are needed to better characterize persons who eventually develop gastric cancer. Treatment benefits can vary by ethnicity and region of the world, possibly due to host-related factors. Continued efforts to improve treatment outcome by considering race/ethnicity, country of birth, and other parameters should be a priority.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13(6):607–615

    Article  PubMed  Google Scholar 

  2. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging handbook, 7th edn. Springer, New York

    Google Scholar 

  3. Karpeh MS, Kelsen DP, Tepper JE (2001) Section 3 cancer of the stomach. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer principles & practice of oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 1092–1126, Chapter 33.3

    Google Scholar 

  4. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108

    Article  PubMed  Google Scholar 

  5. Nomura AMY, Stemmermann GN, Chyou PH (1995) Gastric-cancer among the Japanese in Hawaii. Jpn J Cancer Res 86(10):916–923

    Article  CAS  PubMed  Google Scholar 

  6. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5–29

    Article  PubMed  Google Scholar 

  7. NIH National Cancer Institute Surveillance E, and End Results Program (2015) Table 24.15 Cancer of the Stomach (Invasive) SEER Incidence and U.S. Mortality Age-Adjusted Rates and Trends By Race/Ethnicity and Sex. Bethesda, MD 20892–9760. http://seer.cancer.gov/csr/1975_2012/browse_csr.php?sectionSEL=24&pageSEL=sect_24_table.15.html

  8. Gomez SL, Noone A-M, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, Morris C, Kwong S, Fish K, Wilkens LR, Goodman MT, Deapen D, Miller BA (2013) Cancer incidence trends among Asian American populations in the United States, 1990–2008. J Natl Cancer Ins 105(15):1096–1110

    Article  Google Scholar 

  9. Miller BA, Chu KC, Hankey BF, Ries LAG (2008) Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the US. Cancer Causes Control 19(3):227–256

    Article  PubMed  Google Scholar 

  10. Kim J, Sun CL, Mailey B, Prendergast C, Artinyan A, Bhatia S, Pigazzi A, Ellenhorn JD (2010) Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. Ann Oncol 21(1):152–160

    Article  CAS  PubMed  Google Scholar 

  11. Kunz PL, Gubens M, Fisher GA, Ford JM, Lichtensztajn DY, Clarke CA (2012) Long-term survivors of gastric cancer: a California population-based study. J Clin Oncol 30(28):3507–3515

    Article  PubMed  Google Scholar 

  12. Howard JH, Hiles JM, Leung AM, Stern SL, Bilchik AJ (2015) Race influences stage-specific survival in gastric cancer. Am Surg 81(3):259–267

    PubMed  Google Scholar 

  13. Kim J, Mailey B, Senthil M, Artinyan A, Sun C-L, Bhatia S (2009) Disparities in gastric cancer outcomes among Asian Ethnicities in the USA. Ann Surg Oncol 16(9):2433–2441

    Article  PubMed  Google Scholar 

  14. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49

    CAS  PubMed  Google Scholar 

  15. Tan IB, Ivanova T, Lim KH, Ong CW, Deng N, Lee J, Tan SH, Wu J, Lee MH, Ooi CH, Rha SY, Wong WK, Boussioutas A, Yeoh KG, So J, Yong WP, Tsuburaya A, Grabsch H, Toh HC, Rozen S, Cheong JH, Noh SH, Wan WK, Ajani JA, Lee JS, Tellez MS, Tan P (2011) Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 141(2):476–485, 485.e1–11

    Article  PubMed  PubMed Central  Google Scholar 

  16. Graziano F, Humar B, Guilford P (2003) The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 14(12):1705–1713

    Article  CAS  PubMed  Google Scholar 

  17. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomark Prev 18(7):1945–1952

    Article  Google Scholar 

  18. Nomura A, Grove JS, Stemmermann GN, Severson RK (1990) A prospective-study of stomach-cancer and its relation to diet, cigarettes, and alcohol-consumption. Cancer Res 50(3):627–631

    CAS  PubMed  Google Scholar 

  19. Galanis DJ, Kolonel LN, Lee J, Nomura A (1998) Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study. Int J Epidemiol 27(2):173–180

    Article  CAS  PubMed  Google Scholar 

  20. Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR, Pike MC, Stram DO, Monroe KR, Earle ME, Nagamine FS (2000) A multiethnic cohort in Hawaii and Los Angeles: Baseline characteristics. Am J Epidemiol 151(4):346–357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Nomura AMY, Hankin JH, Kolonel LN, Wilkens LR, Goodman MT, Stemmermann GN (2003) Case–control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control 14(6):547–558

    Article  PubMed  Google Scholar 

  22. Wu AH, Wan P, Bernstein L (2001) A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12(8):721–732

    Article  CAS  PubMed  Google Scholar 

  23. Epplein M, Nomura AMY, Hankin JH, Blaser MJ, Perez-Perez G, Stemmermann GN, Wilkens LR, Kolonel LN (2008) Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case–control study in Hawaii. Cancer Causes Control 19(8):869–877

    Article  PubMed  PubMed Central  Google Scholar 

  24. Marshall B (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1(8336):1273–1275

    Google Scholar 

  25. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic-ulceration. Lancet 1(8390):1311–1315

    Article  CAS  PubMed  Google Scholar 

  26. Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D, Taylor N, Mackinley D, Delima E, Portilla H, Zarama G (1990) Helicobacter-pylori and gastric-carcinoma—serum antibody prevalence in populations with contrasting cancer risks. Cancer 66(12):2569–2574

    Article  CAS  PubMed  Google Scholar 

  27. Munoz N (1994) Is Helicobacter-pylori a cause of gastric-cancer—an appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomark Prev 3(5):445–451

    CAS  Google Scholar 

  28. Munoz N, Pisani P (1994) Helicobacter-pylori and gastric-cancer. Eur J Gastroenterol Hepatol 6(12):1097–1103

    Article  Google Scholar 

  29. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter-pylori infection and the risk of gastric-carcinoma. N Engl J Med 325(16):1127–1131

    Article  CAS  PubMed  Google Scholar 

  30. Talley NJ, Zinsmeister AR, Weaver A, Dimagno EP, Carpenter HA, Perezperez GI, Blaser MJ (1991) Gastric adenocarcinoma and Helicobacter-pylori infection. J Natl Cancer Inst 83(23):1734–1739

    Article  CAS  PubMed  Google Scholar 

  31. IARC Working Group (1994) Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 61:1–241. Lyon, 7–14 June 1994

    Google Scholar 

  32. IARC Working Group monographs (2012) Helicobacter pylori. Lyon, France: International Agency for Research on Cancer (Volume 100B:385–435). http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B-15.pdf

  33. IARC Helicobacter pylori Working Group (2014) Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No. 8). http://www.iarc.fr/en/publications/pdfsonline/wrk/wrk8/index.php

  34. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perezperez GI, Blaser MJ (1991) Helicobacter-Pylori infection and gastric-carcinoma among Japanese-Americans in Hawaii. N Engl J Med 325(16):1132–1136

    Article  CAS  PubMed  Google Scholar 

  35. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ (1991) Mucosal IGA recognition of Helicobacter-pylori 120-KDA protein, peptic-ulceration, and gastric pathology. Lancet 338(8763):332–335

    Article  CAS  PubMed  Google Scholar 

  36. Nomura AMY, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ (2002) Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 186(8):1138–1144

    Article  PubMed  Google Scholar 

  37. Webb PM, Law M, Varghese C, Forman D, Yuan JM, Yu M, Ross R, Limberg PJ, Mark SD, Taylor PR, Dawsey SM, Qiao YL, Aromaa A, Knekt P, Kosunen TU, Heinonen OP, Virtamo J, Tulinius H, Watanabe Y, Ozasa K, Kurata JH, Hansen S, Melby KK, Aase S, Jellum E, Vollset SE, Siman JH, Forsgren A, Berglund G, Floren CH, Lin JT, Chen CJ, Wald NJ, Parsonnet J, Friedman GD, Blaser MJ, Nomura A, Stemmermann GN, Helicobacter Canc Collaborative G (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49(3):347–353

    Article  Google Scholar 

  38. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C (2015) Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 136(2):487–490

    Article  CAS  PubMed  Google Scholar 

  39. Hirayama Y, Kawai T, Otaki J, Kawakami K, Harada Y (2014) Prevalence of Helicobacter pylori infection with healthy subjects in Japan. J Gastroenterol Hepatol 29:16–19

    Article  PubMed  Google Scholar 

  40. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, Cho SH, Oh BH (2007) Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 12(4):333–340

    Article  PubMed  Google Scholar 

  41. Nomura AMY, Wilkens LR, Henderson BE, Epplein M, Kolonel LN (2012) The association of cigarette smoking with gastric cancer: the multiethnic cohort study. Cancer Causes Control 23(1):51–58

    Article  PubMed  Google Scholar 

  42. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N (2008) Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 19(7):689–701

    Article  PubMed  Google Scholar 

  43. Cardenas VM, Graham DY (2005) Smoking and Helicobacter pylori infection in a sample of US adults. Epidemiology 16(4):586–590

    Article  PubMed  Google Scholar 

  44. Shimoyama T, Everett SM, Fukuda S, Axon ATR, Dixon MF, Crabtree JE (2001) Influence of smoking and alcohol on gastric chemokine mRNA expression in patients with Helicobacter pylori infection. J Clin Pathol 54(4):332–334

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL (1990) Effects of mainstream and environmental tobacco-smoke on the immune-system in animals and humans—a review. Crit Rev Toxicol 20(5):369–395

    Article  CAS  PubMed  Google Scholar 

  46. Li S, Kwon SC, Weerasinghe I, Rey MJ, Trinh-Shevrin C (2013) Smoking among Asian Americans: acculturation and gender in the context of tobacco control policies in New York City. Health Promot Pract 14(5 Suppl):18S–28S

    Article  PubMed  PubMed Central  Google Scholar 

  47. Shimazu T, Tsuji I, Inoue M, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsugane S, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan (2008) Alcohol drinking and gastric cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 38(1):8–25

    Article  PubMed  Google Scholar 

  48. Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C, Boffetta P (2012) A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 23(1):28–36

    Article  CAS  PubMed  Google Scholar 

  49. Tramacere I, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, Boffetta P, La Vecchia C, Negri E (2012) A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol 23(2):287–297

    Article  CAS  PubMed  Google Scholar 

  50. Moy KA, Fan YH, Wang RW, Gao YT, Yu MC, Yuan JM (2010) Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomark Prev 19(9):2287–2297

    Article  CAS  Google Scholar 

  51. IARC Working Group (2010) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans VOLUME 96 Alcohol Consumption and Ethyl Carbamate. Lyon, France: International Agency for Research on Cancer. http://monographs.iarc.fr/ENG/Monographs/vol96/mono96.pdf.

  52. Seitz HK, Meier P (2007) The role of acetaldehyde in upper digestive tract cancer in alcoholics. Transl Res 149(6):293–297

    Article  CAS  PubMed  Google Scholar 

  53. Zhu H, Yang X, Zhang C, Zhu C, Tao G, Zhao L, Tang S, Shu Z, Cai J, Dai S, Qin Q, Xu L, Cheng H, Sun X (2013) Red and processed meat intake is associated with higher gastric cancer risk: a meta-analysis of epidemiological observational studies. PLoS One 8(8), e70955

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Cross AJ, Pollock JRA, Bingham SA (2003) Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 63(10):2358–2360

    CAS  PubMed  Google Scholar 

  55. Ward MH, Cross AJ, Abnet CC, Sinha R, Markin RS, Weisenburger DD (2012) Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach. Eur J Cancer Prev 21(2):134–138

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Tricker AR (1997) N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev 6(3):226–268

    Article  CAS  PubMed  Google Scholar 

  57. Wang QB, Chen Y, Wang XL, Gong GQ, Li GP, Li CY (2014) Consumption of fruit, but not vegetables, may reduce risk of gastric cancer: results from a meta-analysis of cohort studies. Eur J Cancer 50(8):1498–1509

    Article  PubMed  Google Scholar 

  58. Chyou PH, Nomura AMY, Hankin JH, Stemmermann GN (1990) A case-cohort study of diet and stomach-cancer. Cancer Res 50(23):7501–7504

    CAS  PubMed  Google Scholar 

  59. Wu Q-J, Yang Y, Wang J, Han L-H, Xiang Y-B (2013) Cruciferous vegetable consumption and gastric cancer risk: a meta-analysis of epidemiological studies. Cancer Sci 104(8):1067–1073

    Article  CAS  PubMed  Google Scholar 

  60. Bergin IL, Sheppard BJ, Fox JG (2003) Helicobacter pylori infection and high dietary salt independently induce atrophic gastritis and intestinal metaplasia in commercially available outbred Mongolian gerbils. Dig Dis Sci 48(3):475–485

    Article  CAS  PubMed  Google Scholar 

  61. Furihata C, Ishida S, Ohta H, Tokuyama T, Katsuyama T, Ogita Z (1996) Cytotoxicity of NaCl, a stomach tumor promoter, and prevention by rice extract in stomach mucose of F344 rats. Cancer Detect Prev 20(3):193–198

    CAS  PubMed  Google Scholar 

  62. D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P (2012) Habitual salt intake and risk of gastric cancer: A meta-analysis of prospective studies. Clin Nutr 31(4):489–498

    Article  PubMed  Google Scholar 

  63. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R (1993) Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218(5):583–592

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, Kim TS, Lee JD, Noh SH, Kim KW (2006) CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics 26(1):143–156

    Article  PubMed  Google Scholar 

  65. Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS (2010) Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer. Endoscopy 42(9):705–713

    Article  CAS  PubMed  Google Scholar 

  66. Leake PA, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A, Law C, Coburn NG (2012) A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 15(Suppl 1):S38–S47

    Article  PubMed  Google Scholar 

  67. Matsuda T, Saika K (2013) The 5-year relative survival rate of stomach cancer in the USA, Europe and Japan. Jpn J Clin Oncol 43(11):1157–1158

    Article  PubMed  Google Scholar 

  68. Park J-M, Kim YH (2008) Current approaches to gastric cancer in Korea. Gastrointest Cancer Res 2(3):137–144

    PubMed  PubMed Central  Google Scholar 

  69. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Dutch Gastric Cancer Group (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908–914

    Article  CAS  PubMed  Google Scholar 

  70. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22(11):2069–2077

    Article  CAS  PubMed  Google Scholar 

  71. Japanese Gastric Cancer A (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2):101–112

    Article  Google Scholar 

  72. Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W (2003) Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 39(11):1603–1609

    Article  CAS  PubMed  Google Scholar 

  73. Sayegh ME, Sano T, Dexter S, Katai H, Fukagawa T, Sasako M (2004) TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer 7(3):140–148

    Article  PubMed  Google Scholar 

  74. Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ, Lee JY, Ryu KW, Nam BH, Kook MC, Kim YW (2015) Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc 81(2):333–341.e1

    Article  PubMed  Google Scholar 

  75. Gotoda T (2006) Endoscopic resection of early gastric cancer: the Japanese perspective. Curr Opin Gastroenterol 22(5):561–569

    Article  PubMed  Google Scholar 

  76. Ribeiro-Mourao F, Pimentel-Nunes P, Dinis-Ribeiro M (2010) Endoscopic submucosal dissection for gastric lesions: results of an European inquiry. Endoscopy 42(10):814–819

    Article  CAS  PubMed  Google Scholar 

  77. Ding J, Liao GQ, Liu HL, Liu S, Tang J (2012) Meta-analysis of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer. J Surg Oncol 105(3):297–303

    Article  PubMed  Google Scholar 

  78. Vinuela EF, Gonen M, Brennan MF, Coit DG, Strong VE (2012) Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg 255(3):446–456

    Article  PubMed  Google Scholar 

  79. Yamamoto M, Rashid OM, Wong J (2015) Surgical management of gastric cancer: the East vs. West perspective. J Gastrointest Oncol 6(1):79–88

    PubMed  PubMed Central  Google Scholar 

  80. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, Grp AG (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357(18):1810–1820

    Article  CAS  PubMed  Google Scholar 

  81. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH, CLASSIC trial investigators (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379(9813):315–21. doi:10.1016/S0140-6736(11)61873-4

    Article  CAS  PubMed  Google Scholar 

  82. Lawler M, Johnston PG (2011) The approval of Teysuno (TM)/S-1 by the European Medicines Agency: a potentially important advance for gastric cancer patients. Oncologist 16(10):E1–E4

    Article  Google Scholar 

  83. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20

    Article  CAS  PubMed  Google Scholar 

  84. Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Geneve J, Lasser P, Rougier P (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29(13):1715–1721

    Article  CAS  PubMed  Google Scholar 

  85. Kang Y, Choi D, Im Y et al (1996) A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer. Proc Am Soc Clin Oncol 15:215, Abstract 503

    Google Scholar 

  86. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730

    Article  CAS  PubMed  Google Scholar 

  87. Enestvedt CK, Diggs BS, Shipley DK, Thomas CR, Billingsley KG (2009) A population-based analysis of surgical and adjuvant therapy for resected gastric cancer: are patients receiving appropriate treatment following publication of the intergroup 0116 results? Gastrointest Cancer Res 3(6):233–238

    PubMed  PubMed Central  Google Scholar 

  88. Lee J, do Lim H, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK (2012) Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol Off J Am Soc Clin Oncol 30(3):268–273

    Article  CAS  Google Scholar 

  89. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, Fleig WE (2010) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 3, CD004064

    PubMed  Google Scholar 

  90. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR, Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358(1):36–46

    Article  CAS  PubMed  Google Scholar 

  91. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA, V325 Study Group (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24(31):4991–4997

    Article  PubMed  Google Scholar 

  92. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J, Kang YK, ToGA Trial Investigators (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697

    Article  CAS  PubMed  Google Scholar 

  93. Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J, Investigators RT (2014) Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 383(9911):31–39

    Article  CAS  PubMed  Google Scholar 

  94. Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, Hironaka S, Sugimoto N, Lipatov O, Kim TY, Cunningham D, Rougier P, Komatsu Y, Ajani J, Emig M, Carlesi R, Ferry D, Chandrawansa K, Schwartz JD, Ohtsu A, RAINBOW Study Group (2014) Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol 15(11):1224–1235

    Article  CAS  PubMed  Google Scholar 

  95. Barzi A, Thara E (2014) Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment. Expert Opin Biol Ther 14(9):1319–1332

    Article  PubMed  Google Scholar 

  96. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, Gotoda T, Lin JT, You WC, Ng EK, Sung JJ, Asia Pacific Working Group on Gastric Cancer (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9(3):279–287

    Article  PubMed  Google Scholar 

  97. Miyamoto A, Kuriyama S, Nishino Y, Tsubono Y, Nakaya N, Ohmori K, Kurashima K, Shibuya D, Tsuji I (2007) Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Prev Med 44(1):12–19

    Article  PubMed  Google Scholar 

  98. Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J (1994) Case–control study of gastric cancer screening in Venezuela. Br J Cancer 69(6):1102–1105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Yoo KY (2008) Cancer control activities in the Republic of Korea. Jpn J Clin Oncol 38(5):327–333

    Article  PubMed  Google Scholar 

  100. Cho E, Kang MH, Choi KS, Suh M, Jun JK, Park EC (2013) Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. Asian Pac J Cancer Prev 14(4):2533–2540

    Article  PubMed  Google Scholar 

  101. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS, China Gastric Cancer Study Group (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291(2):187–194

    Article  CAS  PubMed  Google Scholar 

Download references

Financial Disclosure

Authors’ declaration of personal interests:

None

Declaration of funding interests:

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Afsaneh Barzi M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Barzi, A., Yang, D., Wu, A.H. (2016). Gastric Cancer Among Asian Americans. In: Wu, A., Stram, D. (eds) Cancer Epidemiology Among Asian Americans. Springer, Cham. https://doi.org/10.1007/978-3-319-41118-7_11

Download citation

Publish with us

Policies and ethics